PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, today announced it was selected by X4 Pharmaceuticals, Inc. for the distribution of XOLREMDI™ (mavorixafor), recently approved by the...

April 25, 2024 PITTSBURGH – An exciting advancement for the specialty pharmacy industry, KEEP announced a strategic partnership with PANTHERx Rare, a leader in rare disease product patient access and support services in the US. This collaboration is set...

April 25, 2024 PITTSBURGH – PANTHERx® Rare, the leader in rare disease pharmacy, patient access, and support services in the United States, is pleased to announce three new expansions that will facilitate the company’s continued growth and enhance...

April 1, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Edenbridge Pharmaceuticals for the distribution of Yargesa® (miglustat)...

February 7, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it was selected by Chiesi Global Rare Diseases, a business unit of the Chiesi Group, for the...

December 7, 2023 PITTSBURGH – PANTHERx Rare, the six-time winner of the Annual MMIT Patient Choice Award, once again, has the TOP Net Promoter Score for all independent specialty pharmacies in America for the Third Quarter of 2023 – the third top score...